BackForesee Pharmaceuticals , Ltd. Overview

Foresee Pharmaceuticals , Ltd. Receivables

Foresee Pharmaceuticals , Ltd.'s receivables is $64M.

Get informed when a big investor buys or sells

+ Follow
Receivables
$64.03M
↓ 4.15% YoYΔ $-2.77M vs prior year quarter

Peer trimmed avg / median

Loading

Foresee Pharmaceuticals , Ltd. Receivables History

Loading

Foresee Pharmaceuticals , Ltd. vs. peers: Receivables Comparison

Loading

Foresee Pharmaceuticals , Ltd. Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Foresee Pharmaceuticals , Ltd. (6576.TWO) FAQ

Foresee Pharmaceuticals , Ltd. (6576.TWO) currently reports a receivables of $64M as of June 2026. That compares with $67M in the prior-year period — down 4.1% year over year. Use the charts on this page to explore Foresee Pharmaceuticals , Ltd.'s receivables history and peer comparisons.

Foresee Pharmaceuticals , Ltd.'s receivables decreased from $67M to $64M — a 4.1% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Foresee Pharmaceuticals , Ltd. reported $64M in receivables as of June 2026. That compares with $67M in the prior-year period — down 4.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $64M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Foresee Pharmaceuticals , Ltd., and consider following 6576.TWO for alerts when major investors trade the stock.